The Ghana National Chamber of Commerce and Industry (GNCCI) recently hosted the 4th Annual Chamber Business Awards, a prestigious event honoring outstanding businesses and leaders in Ghana. Ga Matse, the Special Guest of Honor, expressed his privilege in witnessing the celebration of excellence in leadership, innovation, and sustainable business practices […]
Other News
Presidential Daughters’ Mining Controversy Deepens
A recent statement by Ghana’s Lands Ministry defending the presidential daughters’ involvement in mining operations has sparked outrage, with Samuel Okudzeto Ablakwa countering the Ministry’s claims and pointing out discrepancies. The Lands Ministry falsely claimed that Elite Minerals Ghana Limited was incorporated in 2008, but incorporation documents show it was […]
WHO Releases Groundbreaking Guidance to Boost Global Clinical Trials
The World Health Organization (WHO) has launched new guidance to enhance clinical trials worldwide, promoting stronger research and development ecosystems. This move aims to make safe and effective health interventions more accessible and affordable globally. The guidance addresses challenges such as poor trial design, limited participant diversity, and bureaucratic inefficiencies. […]
Global Leaders Unite Against Antimicrobial Resistance: A New Era of Action
FAO, UNEP, WHO and WOAH welcome agreement at UN General Assembly meeting, including target to reduce human deaths from AMR by 10% by 2030. World leaders have pledged to combat antimicrobial resistance (AMR) through a unified front, committing to reduce AMR-related deaths by 10% by 2030. This bold declaration was […]
WHO Announces 2025 Southern Hemisphere Flu Vaccine Composition
The World Health Organization (WHO) has released its recommendations for the 2025 southern hemisphere influenza season vaccine composition. After a 4-day meeting with experts from WHO Collaborating Centres and Essential Regulatory Laboratories, WHO advised: These recommendations guide national vaccine regulatory agencies and pharmaceutical companies in developing, producing, and licensing influenza […]







